Annual report [Section 13 and 15(d), not S-K Item 405]

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]    
Revenue $ 4,103,388 $ 3,126,148
Cost of Revenue 893,466 866,402
Gross Profit 3,209,922 2,259,746
Operating Expenses:    
Selling expenses 341,226 287,676
Administrative expenses 3,026,904 2,074,139
Depreciation and amortization expense 21,847 9,496
Research and development 8,000 189,022
Total Operating Expenses 3,397,977 2,560,333
Gain on the settlement of accounts payable 42,941
Note and interest receivable - related party write off (58,891)
Interest income/expense, net 33,836 44,412
Total Other Income/(Expenses) 33,836 28,462
Loss before income taxes (154,219) (272,125)
Provision for income taxes from continuing operations 0 0
Net (loss) (154,219) (272,125)
Preferred stock dividends Series A Preferred (41,036) (41,148)
Net (loss) attributable to common stockholders $ (195,255) $ (313,273)
Net (loss) per common share - basic $ (0.00) $ (0.00)
Net (loss) per common share - diluted $ (0.00) $ (0.00)
Weighted Average of number of shares outstanding basic 229,238,304 229,160,695
Weighted Average of number of shares outstanding diluted 229,238,304 229,160,695